Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Finance.
Press releases published on May 12, 2025
Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May
GlobeNewswire
·
May 12, 2025
RESEARCH TRIANGLE PARK, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic …
IMUNON Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
First site initiated for Phase 3 OVATION 3 study of IMNN-001 in treatment of newly diagnosed advanced ovarian cancer New data from Phase 2 OVATION 2 study of IMNN-001 accepted for oral presentation at 2025 ASCO Annual Meeting Company to hold conference …
Oxford Lane Capital Corp. Schedules Fourth Fiscal Quarter Earnings Release and Conference Call for May 19, 2025
GlobeNewswire
·
May 12, 2025
GREENWICH, Conn., May 12, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) announced today that it will hold a …
IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products
GlobeNewswire
·
May 12, 2025
Company receives ISCT abstract award for the analytical characterization of its manufactured gamma-delta T cell therapies in the INB-100 trial, which has demonstrated durable, relapse-free survival in AML patients. IN8bio’s proprietary gamma-delta T cell …
Longevity Health Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire
·
May 12, 2025
PITTSBURGH, May 12, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (NASDAQ: XAGE) (“Longevity” or the “Company”), a bio-aesthetics company focused on longevity and healthy aging, today announced that it has resolved to effect a reverse stock …
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2025
GlobeNewswire
·
May 12, 2025
Successful completion of €30 Million capital increase, with strong international demand and oversubscription Awarded non-refundable EU grant of €13.26 Million through the first Important Project of Common European Interest (IPCEI) in the health sector ( …
CHAR Tech Closes C$2M Private Placement with The BMI Group
GlobeNewswire
·
May 12, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- CHAR Technologies Ltd. (“CHAR Tech” or “the Company”) (TSXV:YES) is pleased to announce the successful completion …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
May 12, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
Bitget Delivers Critical Aid to Earthquake-Affected Families in Myanmar
GlobeNewswire
·
May 12, 2025
BANGKOK, May 12, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has mobilized relief efforts for vulnerable communities in Myanmar following the devastating 7.7 magnitude earthquake that struck the Sagaing region on …
Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
GlobeNewswire
·
May 12, 2025
ANN ARBOR, Mich., May 12, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs Limited (together, Micro Labs). This agreement resolves the …
Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
GlobeNewswire
·
May 12, 2025
GREENWICH, Conn., May 12, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Media …
Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
GlobeNewswire
·
May 12, 2025
Data presentation included efficacy and biomarker analyses from the NAVIGATE trial (n=287). Belapectin 2 mg/kg demonstrated a statistically significant reduction in new varices at 18 months in the per-protocol population (p=0.04). Significantly fewer …
Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement
GlobeNewswire
·
May 12, 2025
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today addresses frequently asked stockholder …
Pieridae Energy Changes Name to Cavvy Energy
GlobeNewswire
·
May 12, 2025
Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, May 12, 2025 (GLOBE NEWSWIRE) -- Cavvy Energy Ltd. (formerly Pieridae Energy Limited) (“Cavvy” or the “Company”) (TSX:PEA) is pleased to announce …
TX Rail Products, Inc. Reports Financial Results for Second Quarter of Fiscal 2025
GlobeNewswire
·
May 12, 2025
ASHLAND, Ky., May 12, 2025 (GLOBE NEWSWIRE) -- TX Rail Products, Inc. (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced financial results for the …
MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 12, 2025
Topline results for the Phase 2 Avail™ evaluating canvuparatide in patients with hypoparathyroidism expected in 3Q 2025 Investigational New Drug submission for MBX 4291 on track for 2Q 2025 $240.8 million in cash, cash equivalents and marketable securities …
ArriVent BioPharma Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Completed enrollment in global pivotal Phase 3 study for firmonertinib monotherapy in first-line NSCLC harboring EGFR exon 20 insertion mutations Planned update for development of firmonertinib in first-line NSCLC PACC mutations in Q2 2025 First IND for …
nuVizz and Ford Motor Company to Share Keys to 96% Parts Delivery Success at Home Delivery World
GlobeNewswire
·
May 12, 2025
ATLANTA, May 12, 2025 (GLOBE NEWSWIRE) -- nuVizz, a leading innovator in last-mile transportation management solutions (TMS), will present alongside Ford Motor Company at Home Delivery World 2025, one of North America’s premier logistics and supply chain …
Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025
GlobeNewswire
·
May 12, 2025
WARRINGTON, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
DeFi Development Corp. Purchases Record 172,670 SOL, Surpasses $100M in Treasury Holdings
GlobeNewswire
·
May 12, 2025
BOCA RATON, FL, May 12, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) announced today the purchase of 172,670 Solana (“SOL”) at an average purchase price of $136.81 and valued at approximately $23.6 million. This marks the …